Growth Metrics

Ocugen (OCGN) Net Cash Flow Growth (1y) (2015 - 2026)

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) NCF Growth (1y) (Qtr)
1 Quantum Biopharma 1,216,509.61 Bn 1,216,509.61 Bn - 198.34%
2 Alterity Therapeutics 764,224.41 Bn 764,224.38 Bn - -
3 Legend Biotech 2,716.00 Bn 2,715.71 Bn 242.10 Mn 467.41%
4 Nanobiotix 2,248.83 Bn 2,248.77 Bn - -
5 Akari Therapeutics 1,951.18 Bn 1,951.17 Bn - -14,223.53%
6 Vertex Pharmaceuticals 113.69 Bn 106.44 Bn 2.59 Bn 453.08%
7 Evaxion A 64.16 Bn 64.14 Bn - -
8 Regeneron Pharmaceuticals 63.94 Bn 55.18 Bn 3.31 Bn -125.22%
9 Alnylam Pharmaceuticals 40.13 Bn 37.12 Bn 959.66 Mn 53.46%
10 Ocugen 452.01 Mn 452.01 Mn - 163.68%

Historic Data

Download Data 🔒
DateValue
Mar 31, 2026 163.68%
Dec 31, 2025 -170.69%
Sep 30, 2025 -76.06%
Jun 30, 2025 -3.64%
Mar 31, 2025 -58.14%
Dec 31, 2024 241.31%
Sep 30, 2024 234.50%
Jun 30, 2024 -547.18%
Mar 31, 2024 -40.73%
Dec 31, 2023 41.72%
Sep 30, 2023 -27.44%
Jun 30, 2023 115.55%
Mar 31, 2023 -126.72%
Dec 31, 2022 -93.96%
Sep 30, 2022 -61.86%
Jun 30, 2022 -121.07%
Mar 31, 2022 67.75%
Dec 31, 2021 -351.19%
Sep 30, 2021 -300.41%
Jun 30, 2021 501.70%
Mar 31, 2021 588.19%
Dec 31, 2020 162.78%
Sep 30, 2020 -71.70%
Jun 30, 2020 3,084.64%
Mar 31, 2020 -222.29%
Dec 31, 2019 -818.43%
Sep 30, 2019 372.87%
Jun 30, 2019 105.49%
Mar 31, 2019 -115.65%
Dec 31, 2018 76.98%
Sep 30, 2018 -2,370.71%
Jun 30, 2018 -15.88%
Mar 31, 2018 154.24%
Dec 31, 2017 38.93%
Sep 30, 2017 -98.93%
Jun 30, 2017 16.63%
Mar 31, 2017 -93.74%
Dec 31, 2016 16.34%
Sep 30, 2016 394.28%
Jun 30, 2016 12.41%
Mar 31, 2016 -64.34%
Dec 31, 2015 -113.16%
Sep 30, 2015 -65.98%
Jun 30, 2015 -280.23%
Mar 31, 2015 9.21%